Doctors Details

Dr. Joydeep Ghosh
Senior Consultant18 Years of Experience
Medical Oncologist
Apollo Gleneagles Hospital, Kolkata
MBBS, MD, DM
Reg. No.:2604, West Bengal Medical Council, 2007
English
Get Free Evaluation
About Dr. Joydeep Ghosh
- Dr. Joydeep Ghosh is a highly skilled Medical Oncologist with 17 years of extensive experience.
- He obtained his MBBS degree from Medical College and Hospital, Kolkata, in 2007.
- Furthering his specialization, he pursued an MD in General Medicine from the Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital (IPGMER and SSKM hospital) in 2011.
- Dr. Ghosh then pursued DM in Oncology from Tata Medical Center Mumbai in 2016, solidifying his specialization in oncology and cancer care.
- His specialization includes treating breast cancer, gynecological cancers, and gastrointestinal cancers.Â
- He is known for using the latest advancements in cancer treatment, such as hormone therapy, targeted therapy, and immunotherapy.
- Devoted to providing high-quality care, Dr. Ghosh continually updates his knowledge and skills in oncology, a rapidly evolving field.
- He is actively involved in research and academic pursuits, contributing to advancements in oncology and sharing his knowledge with the medical community through publications and presentations.
- Patients trust Dr. Ghosh for his compassionate approach, extensive expertise, and commitment to delivering personalized care tailored to each individual's needs.
- His professional affiliations and memberships include associations with prestigious medical societies, which reflect his dedication to staying current with the latest developments in oncology practice.
Paper Published by Dr. Joydeep Ghosh
- Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in the Era of Targeted Therapy: Scientifically Relevant or Natural Selection?
- Perspective of Oncology Patients During COVID-19 Pandemic: A Prospective Observational Study From India
- Outcome of COVID-19 in Solid Organ Malignancies: Experience From a Tertiary Cancer Center in Eastern India
- 32P Clinical profile and presentation of patients with gastroenteropancreatic neuroendocrine neoplasms: An updated dataset from India
- Real-world experience with maintenance PARPi plus minus Bevacizumab in newly diagnosed advanced ovarian cancer with Germline BRCA or HRD positive
- Real-world study of safety and efficacy of lorlatinib as second line and beyond in ALK-rearranged advanced non-small cell lung cancer patients in India – a multicentre chart review study (ROSELAND)
- EP156/#642 Survival outcomes in advanced stage operable carcinoma endometrium: experience of surgical treatment at a tertiary care cancer center
- 287MO Real-world experience with maintenance PARP inhibitor plus minus bevacizumab in newly diagnosed advanced ovarian cancer with germline BRCA mutations or homologous recombination deficiency (HRD) positive
- Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) — Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) Study
- 272P Correlation of dihydropyrimidine dehydrogenase gene mutation with toxicity among gastrointestinal cancers (GI) taking 5-fluorouracil-based chemotherapy: Experience from a tertiary cancer center in the eastern part of India
Experience of Dr. Joydeep Ghosh
- Medical Consultant, TATA MEDICAL CENTER - 2023
- DM Resident, TATA MEMORIAL HOSPITAL -2016
- Senior Registrar, Apollo Hospitals - 2012
- MD trainee, IPGMER and SSKM hospital - 2011
Education of Dr. Joydeep Ghosh
- MBBS -Â Medical College and Hospital, Kolkata - 2007
- MD (Internal Medicine) - Institute of Post-Graduate Medical Education and Research and Seth Sukhlal Karnani Memorial Hospital (IPGMER and SSKM hospital) - 2011
- DM (Medical Oncology) Tata Medical Center Mumbai - 2016
Top Oncology Doctors in India
Delivering Quality Care, Trusted Globally